Novo Nordisk invests €432 million to expand Athlone facility for global Wegovy pill supply
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
Asahi Kasei Pharma receives worldwide exclusive rights for the research, development, manufacturing, and marketing of the active ingredients
Nadda underlined that India’s policy framework is aligned with this transformation
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
40+ most innovative startups with disruptive contributions across MedTech, Medical Devices, BioPharma, Cell and Gene Therapy, AI and ML, Nutraceuticals, and Biomarkers exhibited their cutting-edge solutions
This transaction fundamentally strengthens Scinai's CDMO platform
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
The initiative, delivered in collaboration with Accenture, integrates digitally enabled operating models powered by advanced analytics and AI across the company’s procurement, manufacturing, and distribution networks
Subscribe To Our Newsletter & Stay Updated